Aliases: NBP16, PC2
Chromosome No: 17
Chromosome Band: 17q25.3
Genetic Category: Rare single gene variant
ASD Reports: 3
Recent Reports: 0
Annotated variants: 2
Associated CNVs: 10
Evidence score: 2
| Associated Disorders: |
|
Relevance to Autism
To evaluate the effects of ASD-associated de novo variants in a family relative context, Kim et al., 2025 defined within-family standardized deviations (WFSD) by subtracting phenotype scores of unaffected family members and standardizing the result in 21,735 families from three ASD cohorts (the Korean Autism cohort, the Simons Simplex Collection, and SPARK); their analysis found that more genes enriched in de novo damaging protein-truncating variants (LOEUF < 0.37) and missense variants (MPC > 2) were identified using WFSD compared to raw phenotype scores, with 38 genes uniquely identified in the WFSD group, including the CBX4 gene. A de novo loss-of-function variant in CBX4 was identified in an SSC proband in Iossifov et al., 2014, while a de novo missense variant with a MPC > 2 was identified in a MSSNG proband in Zhou et al., 2022.
Molecular Function
Enables SUMO binding activity; SUMO ligase activity; and enzyme binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in nuclear body. Part of PRC1 complex.



